NBY - NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q3 2021 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jody Cain – Investor Relations, LHA Justin Hall – Chief Executive Officer and General Counsel Andy Jones – Chief Financial Officer Audrey Kunin – Chief Product Officer Conference Call Participants Jeffrey Cohen – Ladenburg Thalmann Edward Woo – Ascendiant Capital Presentation Operator Good day, and welcome to the NovaBay Pharmaceuticals Third Quarter 2021 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead. Jody Cain This is Jody Cain with LHA. Thank you for participating in today’s call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel; Andy Jones, Chief Financial

For further details see:

NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q3 2021 Results - Earnings Call Transcript